nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—CYP3A4—Temozolomide—brain cancer	0.163	0.417	CbGbCtD
Telaprevir—CYP3A4—Lomustine—brain cancer	0.138	0.354	CbGbCtD
Telaprevir—ABCB1—Etoposide—brain cancer	0.0558	0.143	CbGbCtD
Telaprevir—CTSK—skull—brain cancer	0.0454	0.158	CbGeAlD
Telaprevir—CYP3A4—Etoposide—brain cancer	0.0335	0.0857	CbGbCtD
Telaprevir—CMA1—blood vessel—brain cancer	0.0291	0.101	CbGeAlD
Telaprevir—CELA1—endocrine gland—brain cancer	0.0171	0.0595	CbGeAlD
Telaprevir—CELA1—head—brain cancer	0.0169	0.0587	CbGeAlD
Telaprevir—CELA1—central nervous system—brain cancer	0.0154	0.0536	CbGeAlD
Telaprevir—CELA1—brain—brain cancer	0.0123	0.0426	CbGeAlD
Telaprevir—CMA1—endocrine gland—brain cancer	0.00892	0.031	CbGeAlD
Telaprevir—CTSS—telencephalon—brain cancer	0.00798	0.0277	CbGeAlD
Telaprevir—Lymphopenia—Temozolomide—brain cancer	0.00779	0.0294	CcSEcCtD
Telaprevir—CTSK—gonad—brain cancer	0.0076	0.0264	CbGeAlD
Telaprevir—CTSK—pituitary gland—brain cancer	0.00742	0.0258	CbGeAlD
Telaprevir—CTSK—medulla oblongata—brain cancer	0.00716	0.0249	CbGeAlD
Telaprevir—Haemorrhoids—Temozolomide—brain cancer	0.00678	0.0256	CcSEcCtD
Telaprevir—CTSS—gonad—brain cancer	0.00666	0.0231	CbGeAlD
Telaprevir—CTSS—pituitary gland—brain cancer	0.0065	0.0226	CbGeAlD
Telaprevir—Oral candidiasis—Carmustine—brain cancer	0.00649	0.0245	CcSEcCtD
Telaprevir—CTSK—spinal cord—brain cancer	0.00638	0.0222	CbGeAlD
Telaprevir—Oral candidiasis—Temozolomide—brain cancer	0.00627	0.0237	CcSEcCtD
Telaprevir—CTSS—medulla oblongata—brain cancer	0.00627	0.0218	CbGeAlD
Telaprevir—Anorectal discomfort—Etoposide—brain cancer	0.00583	0.022	CcSEcCtD
Telaprevir—CTSK—endocrine gland—brain cancer	0.00575	0.02	CbGeAlD
Telaprevir—CTSS—midbrain—brain cancer	0.00573	0.0199	CbGeAlD
Telaprevir—CTSK—head—brain cancer	0.00567	0.0197	CbGeAlD
Telaprevir—CTSS—spinal cord—brain cancer	0.00559	0.0194	CbGeAlD
Telaprevir—Hyperuricaemia—Hydroxyurea—brain cancer	0.0055	0.0208	CcSEcCtD
Telaprevir—Blood uric acid increased—Hydroxyurea—brain cancer	0.0052	0.0196	CcSEcCtD
Telaprevir—CTSK—central nervous system—brain cancer	0.00518	0.018	CbGeAlD
Telaprevir—CTSK—cerebellum—brain cancer	0.00506	0.0176	CbGeAlD
Telaprevir—CTSS—endocrine gland—brain cancer	0.00503	0.0175	CbGeAlD
Telaprevir—CTSS—head—brain cancer	0.00497	0.0173	CbGeAlD
Telaprevir—Endocrine disorder—Temozolomide—brain cancer	0.00481	0.0182	CcSEcCtD
Telaprevir—CTSS—central nervous system—brain cancer	0.00454	0.0158	CbGeAlD
Telaprevir—CTSK—Osteoclast Signaling—SPP1—brain cancer	0.00444	0.0783	CbGpPWpGaD
Telaprevir—CTSS—cerebellum—brain cancer	0.00443	0.0154	CbGeAlD
Telaprevir—Hyperbilirubinaemia—Temozolomide—brain cancer	0.00438	0.0165	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00431	0.0163	CcSEcCtD
Telaprevir—Infection—Carboplatin—brain cancer	0.00421	0.0159	CcSEcCtD
Telaprevir—CTSK—brain—brain cancer	0.00411	0.0143	CbGeAlD
Telaprevir—Eosinophilia—Procarbazine—brain cancer	0.0041	0.0155	CcSEcCtD
Telaprevir—Renal failure acute—Hydroxyurea—brain cancer	0.00401	0.0151	CcSEcCtD
Telaprevir—Candida infection—Carmustine—brain cancer	0.00394	0.0149	CcSEcCtD
Telaprevir—Candida infection—Temozolomide—brain cancer	0.00381	0.0144	CcSEcCtD
Telaprevir—Infection—Lomustine—brain cancer	0.00368	0.0139	CcSEcCtD
Telaprevir—Thrombocytopenia—Lomustine—brain cancer	0.00363	0.0137	CcSEcCtD
Telaprevir—CTSS—brain—brain cancer	0.0036	0.0125	CbGeAlD
Telaprevir—Blood creatinine increased—Hydroxyurea—brain cancer	0.00347	0.0131	CcSEcCtD
Telaprevir—Hyperuricaemia—Etoposide—brain cancer	0.00344	0.013	CcSEcCtD
Telaprevir—ORM1—spinal cord—brain cancer	0.00334	0.0116	CbGeAlD
Telaprevir—Blood uric acid increased—Etoposide—brain cancer	0.00325	0.0123	CcSEcCtD
Telaprevir—CMA1—Degradation of the extracellular matrix—BSG—brain cancer	0.00323	0.057	CbGpPWpGaD
Telaprevir—Candida infection—Etoposide—brain cancer	0.00305	0.0115	CcSEcCtD
Telaprevir—ORM1—endocrine gland—brain cancer	0.00301	0.0104	CbGeAlD
Telaprevir—ABCB1—blood vessel—brain cancer	0.0029	0.0101	CbGeAlD
Telaprevir—CTSK—Degradation of the extracellular matrix—BSG—brain cancer	0.00288	0.0508	CbGpPWpGaD
Telaprevir—Infestation—Hydroxyurea—brain cancer	0.00285	0.0108	CcSEcCtD
Telaprevir—Infestation NOS—Hydroxyurea—brain cancer	0.00285	0.0108	CcSEcCtD
Telaprevir—Hypokalaemia—Carmustine—brain cancer	0.00273	0.0103	CcSEcCtD
Telaprevir—ORM1—central nervous system—brain cancer	0.00271	0.00941	CbGeAlD
Telaprevir—Hepatobiliary disease—Hydroxyurea—brain cancer	0.0027	0.0102	CcSEcCtD
Telaprevir—Anaemia—Procarbazine—brain cancer	0.00266	0.0101	CcSEcCtD
Telaprevir—Hypokalaemia—Temozolomide—brain cancer	0.00263	0.00994	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00261	0.00984	CcSEcCtD
Telaprevir—Syncope—Procarbazine—brain cancer	0.00258	0.00976	CcSEcCtD
Telaprevir—Loss of consciousness—Procarbazine—brain cancer	0.00253	0.00956	CcSEcCtD
Telaprevir—CTSS—Degradation of the extracellular matrix—BSG—brain cancer	0.00237	0.0418	CbGpPWpGaD
Telaprevir—Vomiting—Lomustine—brain cancer	0.00236	0.00889	CcSEcCtD
Telaprevir—Infection—Procarbazine—brain cancer	0.00234	0.00882	CcSEcCtD
Telaprevir—Shock—Procarbazine—brain cancer	0.00231	0.00874	CcSEcCtD
Telaprevir—Thrombocytopenia—Procarbazine—brain cancer	0.0023	0.00869	CcSEcCtD
Telaprevir—Infestation—Temozolomide—brain cancer	0.00223	0.00842	CcSEcCtD
Telaprevir—Infestation NOS—Temozolomide—brain cancer	0.00223	0.00842	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00221	0.00835	CcSEcCtD
Telaprevir—Nausea—Lomustine—brain cancer	0.0022	0.00831	CcSEcCtD
Telaprevir—Hepatobiliary disease—Temozolomide—brain cancer	0.00211	0.00796	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00209	0.00787	CcSEcCtD
Telaprevir—Anaemia—Hydroxyurea—brain cancer	0.00206	0.00778	CcSEcCtD
Telaprevir—Oedema peripheral—Carmustine—brain cancer	0.00204	0.0077	CcSEcCtD
Telaprevir—Fatigue—Procarbazine—brain cancer	0.00203	0.00766	CcSEcCtD
Telaprevir—Urinary tract disorder—Temozolomide—brain cancer	0.00198	0.00746	CcSEcCtD
Telaprevir—Oedema peripheral—Temozolomide—brain cancer	0.00197	0.00744	CcSEcCtD
Telaprevir—Urethral disorder—Temozolomide—brain cancer	0.00196	0.00741	CcSEcCtD
Telaprevir—Eye disorder—Carmustine—brain cancer	0.00194	0.00731	CcSEcCtD
Telaprevir—Erythema multiforme—Temozolomide—brain cancer	0.00189	0.00715	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00189	0.00712	CcSEcCtD
Telaprevir—ALB—brain—brain cancer	0.00189	0.00655	CbGeAlD
Telaprevir—Eye disorder—Temozolomide—brain cancer	0.00187	0.00706	CcSEcCtD
Telaprevir—Urticaria—Procarbazine—brain cancer	0.00187	0.00705	CcSEcCtD
Telaprevir—Infection—Hydroxyurea—brain cancer	0.00181	0.00683	CcSEcCtD
Telaprevir—Malnutrition—Carmustine—brain cancer	0.0018	0.00681	CcSEcCtD
Telaprevir—Nervous system disorder—Hydroxyurea—brain cancer	0.00179	0.00674	CcSEcCtD
Telaprevir—Infestation—Etoposide—brain cancer	0.00178	0.00674	CcSEcCtD
Telaprevir—Infestation NOS—Etoposide—brain cancer	0.00178	0.00674	CcSEcCtD
Telaprevir—Thrombocytopenia—Hydroxyurea—brain cancer	0.00178	0.00673	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00177	0.00668	CcSEcCtD
Telaprevir—Skin disorder—Hydroxyurea—brain cancer	0.00177	0.00668	CcSEcCtD
Telaprevir—Malnutrition—Temozolomide—brain cancer	0.00174	0.00658	CcSEcCtD
Telaprevir—Dysgeusia—Temozolomide—brain cancer	0.00171	0.00644	CcSEcCtD
Telaprevir—Asthenia—Procarbazine—brain cancer	0.00169	0.00637	CcSEcCtD
Telaprevir—Hepatobiliary disease—Etoposide—brain cancer	0.00169	0.00637	CcSEcCtD
Telaprevir—Anaemia—Carmustine—brain cancer	0.00167	0.00629	CcSEcCtD
Telaprevir—Pruritus—Procarbazine—brain cancer	0.00166	0.00628	CcSEcCtD
Telaprevir—Anaemia—Temozolomide—brain cancer	0.00161	0.00608	CcSEcCtD
Telaprevir—Diarrhoea—Procarbazine—brain cancer	0.00161	0.00608	CcSEcCtD
Telaprevir—Urinary tract disorder—Etoposide—brain cancer	0.00158	0.00597	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00157	0.00593	CcSEcCtD
Telaprevir—Urethral disorder—Etoposide—brain cancer	0.00157	0.00593	CcSEcCtD
Telaprevir—Fatigue—Hydroxyurea—brain cancer	0.00157	0.00593	CcSEcCtD
Telaprevir—Dizziness—Procarbazine—brain cancer	0.00156	0.00587	CcSEcCtD
Telaprevir—Erythema multiforme—Etoposide—brain cancer	0.00151	0.00572	CcSEcCtD
Telaprevir—Eye disorder—Etoposide—brain cancer	0.0015	0.00565	CcSEcCtD
Telaprevir—Vomiting—Procarbazine—brain cancer	0.0015	0.00565	CcSEcCtD
Telaprevir—Rash—Procarbazine—brain cancer	0.00148	0.0056	CcSEcCtD
Telaprevir—Dermatitis—Procarbazine—brain cancer	0.00148	0.00559	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00147	0.00556	CcSEcCtD
Telaprevir—Infection—Carmustine—brain cancer	0.00146	0.00552	CcSEcCtD
Telaprevir—Thrombocytopenia—Carmustine—brain cancer	0.00144	0.00544	CcSEcCtD
Telaprevir—Infection—Temozolomide—brain cancer	0.00141	0.00533	CcSEcCtD
Telaprevir—ABCB1—telencephalon—brain cancer	0.00141	0.00489	CbGeAlD
Telaprevir—Nausea—Procarbazine—brain cancer	0.0014	0.00527	CcSEcCtD
Telaprevir—Nervous system disorder—Temozolomide—brain cancer	0.00139	0.00527	CcSEcCtD
Telaprevir—Thrombocytopenia—Temozolomide—brain cancer	0.00139	0.00526	CcSEcCtD
Telaprevir—Skin disorder—Temozolomide—brain cancer	0.00138	0.00522	CcSEcCtD
Telaprevir—Dysgeusia—Etoposide—brain cancer	0.00137	0.00516	CcSEcCtD
Telaprevir—CMA1—Extracellular matrix organization—BSG—brain cancer	0.00135	0.0239	CbGpPWpGaD
Telaprevir—Asthenia—Hydroxyurea—brain cancer	0.00131	0.00493	CcSEcCtD
Telaprevir—Anaemia—Etoposide—brain cancer	0.00129	0.00487	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Carmustine—brain cancer	0.00127	0.0048	CcSEcCtD
Telaprevir—CMA1—Degradation of the extracellular matrix—SPP1—brain cancer	0.00126	0.0223	CbGpPWpGaD
Telaprevir—CYP3A4—endocrine gland—brain cancer	0.00125	0.00436	CbGeAlD
Telaprevir—Diarrhoea—Hydroxyurea—brain cancer	0.00125	0.0047	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Temozolomide—brain cancer	0.00123	0.00464	CcSEcCtD
Telaprevir—Fatigue—Temozolomide—brain cancer	0.00123	0.00463	CcSEcCtD
Telaprevir—Loss of consciousness—Etoposide—brain cancer	0.00123	0.00463	CcSEcCtD
Telaprevir—CTSK—Extracellular matrix organization—BSG—brain cancer	0.00121	0.0213	CbGpPWpGaD
Telaprevir—Dizziness—Hydroxyurea—brain cancer	0.0012	0.00454	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00118	0.00445	CcSEcCtD
Telaprevir—ABCB1—gonad—brain cancer	0.00118	0.00408	CbGeAlD
Telaprevir—Vomiting—Hydroxyurea—brain cancer	0.00116	0.00437	CcSEcCtD
Telaprevir—Rash—Hydroxyurea—brain cancer	0.00115	0.00433	CcSEcCtD
Telaprevir—Dermatitis—Hydroxyurea—brain cancer	0.00115	0.00433	CcSEcCtD
Telaprevir—ABCB1—pituitary gland—brain cancer	0.00115	0.00398	CbGeAlD
Telaprevir—CYP3A4—central nervous system—brain cancer	0.00113	0.00393	CbGeAlD
Telaprevir—Infection—Etoposide—brain cancer	0.00113	0.00427	CcSEcCtD
Telaprevir—Urticaria—Temozolomide—brain cancer	0.00113	0.00427	CcSEcCtD
Telaprevir—CTSK—Degradation of the extracellular matrix—SPP1—brain cancer	0.00113	0.0198	CbGpPWpGaD
Telaprevir—Thrombocytopenia—Etoposide—brain cancer	0.00111	0.00421	CcSEcCtD
Telaprevir—ABCB1—medulla oblongata—brain cancer	0.00111	0.00384	CbGeAlD
Telaprevir—Skin disorder—Etoposide—brain cancer	0.00111	0.00417	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—VAV1—brain cancer	0.0011	0.0194	CbGpPWpGaD
Telaprevir—Nausea—Hydroxyurea—brain cancer	0.00108	0.00408	CcSEcCtD
Telaprevir—Asthenia—Carmustine—brain cancer	0.00106	0.00399	CcSEcCtD
Telaprevir—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00104	0.0184	CbGpPWpGaD
Telaprevir—CTSK—RANKL/RANK Signaling Pathway—RELA—brain cancer	0.00103	0.0182	CbGpPWpGaD
Telaprevir—Asthenia—Temozolomide—brain cancer	0.00102	0.00385	CcSEcCtD
Telaprevir—ABCB1—midbrain—brain cancer	0.00101	0.00351	CbGeAlD
Telaprevir—Diarrhoea—Carmustine—brain cancer	0.00101	0.0038	CcSEcCtD
Telaprevir—Pruritus—Temozolomide—brain cancer	0.00101	0.0038	CcSEcCtD
Telaprevir—CTSS—Extracellular matrix organization—BSG—brain cancer	0.000995	0.0175	CbGpPWpGaD
Telaprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000993	0.0175	CbGpPWpGaD
Telaprevir—ABCB1—spinal cord—brain cancer	0.000987	0.00343	CbGeAlD
Telaprevir—Gastrointestinal disorder—Etoposide—brain cancer	0.000982	0.00371	CcSEcCtD
Telaprevir—Fatigue—Etoposide—brain cancer	0.000981	0.0037	CcSEcCtD
Telaprevir—Dizziness—Carmustine—brain cancer	0.000973	0.00367	CcSEcCtD
Telaprevir—Diarrhoea—Temozolomide—brain cancer	0.000973	0.00367	CcSEcCtD
Telaprevir—Dizziness—Temozolomide—brain cancer	0.00094	0.00355	CcSEcCtD
Telaprevir—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000936	0.0165	CbGpPWpGaD
Telaprevir—Vomiting—Carmustine—brain cancer	0.000936	0.00353	CcSEcCtD
Telaprevir—Rash—Carmustine—brain cancer	0.000928	0.0035	CcSEcCtD
Telaprevir—Dermatitis—Carmustine—brain cancer	0.000927	0.0035	CcSEcCtD
Telaprevir—CTSS—Degradation of the extracellular matrix—SPP1—brain cancer	0.000927	0.0163	CbGpPWpGaD
Telaprevir—Vomiting—Temozolomide—brain cancer	0.000904	0.00341	CcSEcCtD
Telaprevir—Urticaria—Etoposide—brain cancer	0.000904	0.00341	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—PDGFRA—brain cancer	0.0009	0.0159	CbGpPWpGaD
Telaprevir—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.0009	0.0159	CbGpPWpGaD
Telaprevir—Rash—Temozolomide—brain cancer	0.000897	0.00339	CcSEcCtD
Telaprevir—Dermatitis—Temozolomide—brain cancer	0.000896	0.00338	CcSEcCtD
Telaprevir—ABCB1—endocrine gland—brain cancer	0.000888	0.00309	CbGeAlD
Telaprevir—ABCB1—head—brain cancer	0.000877	0.00305	CbGeAlD
Telaprevir—Nausea—Carmustine—brain cancer	0.000874	0.0033	CcSEcCtD
Telaprevir—Nausea—Temozolomide—brain cancer	0.000845	0.00319	CcSEcCtD
Telaprevir—Asthenia—Etoposide—brain cancer	0.000816	0.00308	CcSEcCtD
Telaprevir—Pruritus—Etoposide—brain cancer	0.000805	0.00304	CcSEcCtD
Telaprevir—ABCB1—central nervous system—brain cancer	0.0008	0.00278	CbGeAlD
Telaprevir—CMA1—Signaling by SCF-KIT—IRS2—brain cancer	0.00079	0.0139	CbGpPWpGaD
Telaprevir—ABCB1—cerebellum—brain cancer	0.000782	0.00272	CbGeAlD
Telaprevir—Diarrhoea—Etoposide—brain cancer	0.000779	0.00294	CcSEcCtD
Telaprevir—Dizziness—Etoposide—brain cancer	0.000753	0.00284	CcSEcCtD
Telaprevir—Vomiting—Etoposide—brain cancer	0.000724	0.00273	CcSEcCtD
Telaprevir—Rash—Etoposide—brain cancer	0.000718	0.00271	CcSEcCtD
Telaprevir—Dermatitis—Etoposide—brain cancer	0.000717	0.00271	CcSEcCtD
Telaprevir—CMA1—Peptide hormone metabolism—CTNNB1—brain cancer	0.000711	0.0125	CbGpPWpGaD
Telaprevir—Nausea—Etoposide—brain cancer	0.000676	0.00255	CcSEcCtD
Telaprevir—CTSS—Class I MHC mediated antigen processing & presentation—SKP2—brain cancer	0.000665	0.0117	CbGpPWpGaD
Telaprevir—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000643	0.0113	CbGpPWpGaD
Telaprevir—ABCB1—brain—brain cancer	0.000635	0.00221	CbGeAlD
Telaprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000612	0.0108	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—OR14C36—brain cancer	0.000559	0.00985	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—OR4C12—brain cancer	0.000559	0.00985	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—ERBB2—brain cancer	0.000542	0.00955	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—SPP1—brain cancer	0.000529	0.00933	CbGpPWpGaD
Telaprevir—CTSK—Toll-Like Receptors Cascades—RELA—brain cancer	0.000486	0.00857	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—DTX2—brain cancer	0.000475	0.00838	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—SPP1—brain cancer	0.000471	0.00831	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—STAT3—brain cancer	0.000413	0.00728	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000406	0.00716	CbGpPWpGaD
Telaprevir—CTSS—Toll-Like Receptors Cascades—RELA—brain cancer	0.0004	0.00706	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—SKP2—brain cancer	0.0004	0.00705	CbGpPWpGaD
Telaprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000389	0.00685	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—SPP1—brain cancer	0.000388	0.00684	CbGpPWpGaD
Telaprevir—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000383	0.00676	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—EGFR—brain cancer	0.000376	0.00662	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000362	0.00638	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PTCH2—brain cancer	0.00036	0.00635	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HES5—brain cancer	0.000349	0.00615	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—STRADA—brain cancer	0.000339	0.00597	CbGpPWpGaD
Telaprevir—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.00033	0.00582	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—SKP2—brain cancer	0.000329	0.0058	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000319	0.00563	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—VAV1—brain cancer	0.000317	0.00559	CbGpPWpGaD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000315	0.00555	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—VAV1—brain cancer	0.000305	0.00537	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	0.000294	0.00518	CbGpPWpGaD
Telaprevir—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000293	0.00516	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ABR—brain cancer	0.000283	0.00498	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—GLI2—brain cancer	0.000273	0.00481	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—VAV1—brain cancer	0.000261	0.00461	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—PDGFRA—brain cancer	0.00026	0.00458	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—GLI1—brain cancer	0.000257	0.00452	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000254	0.00447	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—VAV1—brain cancer	0.000251	0.00442	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—PDGFRA—brain cancer	0.00025	0.0044	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SUFU—brain cancer	0.000243	0.00429	CbGpPWpGaD
Telaprevir—CTSK—Immune System—SKP2—brain cancer	0.000242	0.00427	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—SOD2—brain cancer	0.000239	0.00421	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—GFAP—brain cancer	0.000235	0.00414	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—IRS2—brain cancer	0.000228	0.00402	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HEY1—brain cancer	0.000223	0.00392	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—IRS2—brain cancer	0.000219	0.00386	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—DLL1—brain cancer	0.000218	0.00385	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—PDGFRA—brain cancer	0.000214	0.00377	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PDGFRA—brain cancer	0.000205	0.00362	CbGpPWpGaD
Telaprevir—CTSS—Immune System—SKP2—brain cancer	0.0002	0.00352	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—SOD2—brain cancer	0.00019	0.00335	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—IRS2—brain cancer	0.000188	0.00331	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SHH—brain cancer	0.000186	0.00327	CbGpPWpGaD
Telaprevir—CTSK—Immune System—VAV1—brain cancer	0.000185	0.00326	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—IRS2—brain cancer	0.00018	0.00318	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TRPC6—brain cancer	0.000179	0.00315	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SMO—brain cancer	0.000176	0.0031	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PTCH1—brain cancer	0.000176	0.0031	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000173	0.00305	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—RELA—brain cancer	0.00017	0.00299	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000167	0.00295	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000165	0.00291	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MPL—brain cancer	0.000165	0.0029	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—S100A10—brain cancer	0.000158	0.00278	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—RELA—brain cancer	0.000157	0.00278	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—ERBB2—brain cancer	0.000156	0.00276	CbGpPWpGaD
Telaprevir—CTSS—Immune System—VAV1—brain cancer	0.000152	0.00268	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PDGFRA—brain cancer	0.000151	0.00267	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—RELA—brain cancer	0.000151	0.00266	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—ERBB2—brain cancer	0.00015	0.00265	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000144	0.00254	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000141	0.00249	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NOTCH2—brain cancer	0.000141	0.00248	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—RELA—brain cancer	0.000138	0.00244	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CTNNB1—brain cancer	0.000137	0.00241	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000137	0.00241	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	0.000137	0.00241	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—CTNNB1—brain cancer	0.000134	0.00237	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VAV1—brain cancer	0.000134	0.00236	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IRS2—brain cancer	0.000133	0.00234	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—RELA—brain cancer	0.00013	0.00229	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—ERBB2—brain cancer	0.000129	0.00227	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PDGFRA—brain cancer	0.000125	0.0022	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—RELA—brain cancer	0.000124	0.00219	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—IL2—brain cancer	0.000124	0.00219	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—ERBB2—brain cancer	0.000124	0.00218	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.00012	0.00211	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000119	0.0021	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000116	0.00204	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HES1—brain cancer	0.000115	0.00203	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CTNNB1—brain cancer	0.000113	0.00199	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—BSG—brain cancer	0.000111	0.00196	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PDGFRA—brain cancer	0.00011	0.00194	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—RELA—brain cancer	0.00011	0.00194	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IRS2—brain cancer	0.000109	0.00193	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—EGFR—brain cancer	0.000108	0.00191	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000108	0.00191	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SPP1—brain cancer	0.000107	0.00188	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000106	0.00187	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—EGFR—brain cancer	0.000104	0.00184	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IRS2—brain cancer	9.64e-05	0.0017	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	9.49e-05	0.00167	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—IL2—brain cancer	9.44e-05	0.00166	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	9.3e-05	0.00164	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	9.27e-05	0.00163	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	9.19e-05	0.00162	CbGpPWpGaD
Telaprevir—CTSK—Immune System—RELA—brain cancer	9.17e-05	0.00162	CbGpPWpGaD
Telaprevir—CTSK—Immune System—ERBB2—brain cancer	9.11e-05	0.00161	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—VEGFA—brain cancer	9.07e-05	0.0016	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—EGFR—brain cancer	8.93e-05	0.00157	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.7e-05	0.00153	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	8.64e-05	0.00152	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—EGFR—brain cancer	8.57e-05	0.00151	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	8.54e-05	0.00151	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CG—brain cancer	8.51e-05	0.0015	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—APC—brain cancer	8.51e-05	0.0015	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL2—brain cancer	8.26e-05	0.00146	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	8.14e-05	0.00143	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—VEGFA—brain cancer	8.03e-05	0.00141	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—brain cancer	7.99e-05	0.00141	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CTNNB1—brain cancer	7.97e-05	0.00141	CbGpPWpGaD
Telaprevir—CTSS—Immune System—RELA—brain cancer	7.55e-05	0.00133	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ERBB2—brain cancer	7.5e-05	0.00132	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TRPC6—brain cancer	7.29e-05	0.00128	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	7.03e-05	0.00124	CbGpPWpGaD
Telaprevir—CTSK—Immune System—STAT3—brain cancer	6.95e-05	0.00122	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL2—brain cancer	6.8e-05	0.0012	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	6.73e-05	0.00119	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—RELA—brain cancer	6.65e-05	0.00117	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	6.62e-05	0.00117	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ERBB2—brain cancer	6.61e-05	0.00117	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CTNNB1—brain cancer	6.56e-05	0.00116	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EGFR—brain cancer	6.32e-05	0.00111	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	6.31e-05	0.00111	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL2—brain cancer	5.99e-05	0.00106	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCND1—brain cancer	5.84e-05	0.00103	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CTNNB1—brain cancer	5.78e-05	0.00102	CbGpPWpGaD
Telaprevir—CTSS—Immune System—STAT3—brain cancer	5.72e-05	0.00101	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	5.53e-05	0.000974	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VAV1—brain cancer	5.46e-05	0.000962	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP2C9—brain cancer	5.3e-05	0.000934	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EGFR—brain cancer	5.2e-05	0.000917	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.14e-05	0.000906	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VEGFA—brain cancer	5.09e-05	0.000897	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—STAT3—brain cancer	5.04e-05	0.000889	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	4.73e-05	0.000834	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MYC—brain cancer	4.68e-05	0.000826	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP2C9—brain cancer	4.64e-05	0.000819	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EGFR—brain cancer	4.58e-05	0.000808	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.54e-05	0.000801	CbGpPWpGaD
Telaprevir—ALB—Metabolism—BSG—brain cancer	4.51e-05	0.000795	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.5e-05	0.000793	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	4.02e-05	0.000709	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.96e-05	0.000698	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—BSG—brain cancer	3.95e-05	0.000696	CbGpPWpGaD
Telaprevir—ALB—Metabolism—IDH1—brain cancer	3.88e-05	0.000683	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—brain cancer	3.85e-05	0.000678	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.64e-05	0.000642	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.56e-05	0.000628	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CG—brain cancer	3.47e-05	0.000611	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—IDH1—brain cancer	3.4e-05	0.000599	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.16e-05	0.000556	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ENO2—brain cancer	3.06e-05	0.00054	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.99e-05	0.000528	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP2C9—brain cancer	2.86e-05	0.000504	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ENO2—brain cancer	2.68e-05	0.000473	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IL2—brain cancer	2.44e-05	0.00043	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—BSG—brain cancer	2.43e-05	0.000429	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—IDH1—brain cancer	2.09e-05	0.000369	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—brain cancer	2.07e-05	0.000365	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ENO2—brain cancer	1.65e-05	0.000292	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—brain cancer	1.57e-05	0.000276	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CG—brain cancer	1.41e-05	0.000248	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CG—brain cancer	1.23e-05	0.000217	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CG—brain cancer	7.59e-06	0.000134	CbGpPWpGaD
